Peter D. Kies

2021

In 2021, Peter D. Kies earned a total compensation of $2.3M as Chief Financial Officer at Inovio Pharmaceuticals, a 7% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$178,960
Option Awards$860,581
Salary$496,168
Stock Awards$750,726
Other$11,382
Total$2,297,817

Kies received $860.6K in option awards, accounting for 37% of the total pay in 2021.

Kies also received $179K in non-equity incentive plan, $496.2K in salary, $750.7K in stock awards and $11.4K in other compensation.

Rankings

In 2021, Peter D. Kies' compensation ranked 5,488th out of 12,406 executives tracked by ExecPay. In other words, Kies earned more than 55.8% of executives.

ClassificationRankingPercentile
All
5,488
out of 12,406
56th
Division
Manufacturing
2,316
out of 5,492
58th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
281
out of 798
65th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
169
out of 519
67th
Industry
Surgical and Medical Instruments and Apparatus
109
out of 324
66th

Pay ratio

Peter D. Kies' Pay$2,297,817
Median Employee's Pay$180,313
Pay Ratio

13

to 1

In 2021, the annual total compensation of Peter D. Kies was $2,297,817.

The annual total compensation of the median employee at Inovio Pharmaceuticals was $180,313.

The ratio of Peter D. Kies' pay to the pay of median employee was therefore 13 to one.

Source: SEC filing on March 25, 2022.

Kies' colleagues

We found three more compensation records of executives who worked with Peter D. Kies at Inovio Pharmaceuticals in 2021.

2021

J Kim

Inovio Pharmaceuticals

Chief Executive Officer

2021

Jacqueline Shea

Inovio Pharmaceuticals

Chief Operating Officer

2021

Laurent Humeau

Inovio Pharmaceuticals

Chief Scientific Officer

News

You may also like